PRAX (Praxis Precision Medicines) Total Assets: $1,460.20 Mil (As of Mar. 2026)


PRAX Praxis Precision Medicines Inc PRAX
38 GF Score
Price $319.60
GF Value $30.73
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Praxis Precision Medicines Total Assets?

Praxis Precision Medicines PRAX -4.54% 38 Total Assets is $1,460.20 Mil as of Mar. 2026. GuruFocus rates PRAX with a GF Score™ of 38/100 and a GF Value™ of $30.73 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Praxis Precision Medicines's Total Assets for the quarter that ended in Mar. 2026 was $1,460.20 Mil.

During the past 12 months, Praxis Precision Medicines's average Total Assets Growth Rate was 346.70% per year. During the past 3 years, the average Total Assets Growth Rate was 184.90% per year. During the past 5 years, the average Total Assets Growth Rate was 98.40% per year.

During the past 8 years, Praxis Precision Medicines's highest 3-Year average Total Assets Growth Rate was 184.90%. The lowest was 0.40%. And the median was 75.20%.

Total Assets is connected with ROA %. Praxis Precision Medicines's annualized ROA % for the quarter that ended in Mar. 2026 was -30.88%. Total Assets is also linked to Revenue through Asset Turnover. Praxis Precision Medicines's Asset Turnover for the quarter that ended in Mar. 2026 was 0.00.

Praxis Precision Medicines  (NAS:PRAX) Total Assets Explanation

Total Assets is connected with ROA %.

Praxis Precision Medicines's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=-370.244/( (937.907+1460.202)/ 2 )
=-370.244/1199.0545
=-30.88 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Praxis Precision Medicines's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=0/( (937.907+1460.202)/ 2 )
=0/1199.0545
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Praxis Precision Medicines Total Assets Related Terms

Praxis Precision Medicines Total Assets Historical Data

* Premium members only.

The historical data trend for Praxis Precision Medicines's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Praxis Precision Medicines Total Assets Chart

Praxis Precision Medicines Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial 292.75 115.13 87.95 483.11 937.91

Praxis Precision Medicines Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 478.74 452.83 396.39 937.91 1,460.20
PRAX
38GF Score
Praxis Precision Medicines Inc PRAX
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Praxis Precision Medicines Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Praxis Precision Medicines's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=878.136+59.771
=937.91

Praxis Precision Medicines's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=1409.961+50.241
=1,460.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $1,460.20 Mil mean?
Praxis Precision Medicines (PRAX) has a Total Assets of $1,460.20 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Praxis Precision Medicines and its competitors.
Is Praxis Precision Medicines' Total Assets too high?
Praxis Precision Medicines' current Total Assets is $1,460.20 Mil. Overall, Praxis Precision Medicines has a GF Score™ of 38/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Praxis Precision Medicines' Total Assets compare to IBRX and CORT?
Praxis Precision Medicines' Total Assets of $1,460.20 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Praxis Precision Medicines and its competitors. Praxis Precision Medicines's current Total Assets is $1,460.20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Praxis Precision Medicines stock overvalued right now?
Based on GuruFocus' analysis, Praxis Precision Medicines (PRAX) is currently considered Significantly Overvalued. The stock's GF Value™ is $30.73, compared to a current price of $319.60 — trading 940% above its estimated fair value. The current Total Assets is $1,460.20 Mil. Praxis Precision Medicines' overall GF Score™ is 38/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Praxis Precision Medicines (PRAX), the current Total Assets is $1,460.20 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Praxis Precision Medicines (PRAX) Overvalued in 2026?

Based on GuruFocus' analysis, Praxis Precision Medicines stock appears to be overvalued. The current stock price of $319.60 is trading 940% above its estimated GF Value™ of $30.73. GuruFocus considers Praxis Precision Medicines to be Significantly Overvalued.

Key valuation signals for PRAX:

  • Total Assets: $1,460.20 Mil
  • GF Value™: $30.73 vs. price of $319.60 (940% above fair value)
  • GF Score™: 38/100 with 3 warning signs

No single metric tells the full story. See the PRAX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Praxis Precision Medicines Business Description

Address 99 High Street, 30th Floor, Boston, MA, USA, 02110
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.
38GF Score

Get the complete analysis for PRAX

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$319.60
Price
$30.73
GF Value